Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.42 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 4/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30175601 | 1.00 | LMNA (0.44) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 | |
| SCHEMBL17253259 | 0.87 | LMNA (0.47) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 | |
| SCHEMBL15777571 | 0.84 | EHMT2 (0.48) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 | |
| SCHEMBL14059363 | 0.83 | LMNA (0.56) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 | |
| SCHEMBL30613337 | 0.83 | THRB (0.40) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 | |
| SCHEMBL31040491 | 0.83 | ALDH1A1 (0.49) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 | |
| SCHEMBL31040490 | 0.83 | ALDH1A1 (0.49) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 | |
| SCHEMBL844408 | 0.83 | EHMT2 (0.47) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 | |
| SCHEMBL903346 | 0.83 | ALDH1A1 (0.49) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 | |
| SCHEMBL20095020 | 0.82 | LMNA (0.45) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109666121-B | Hybrid dynamic cross-linked polymer and application thereof | 厦门逍扬运动科技有限公司 | 2023-09-22 | — | — | CN | claimed |
| US-20160206750-A1 | BLOCK COPOLYMERS | ROIVANT SCIENCES LTD. (GB) | 2016-07-21 | — | — | US | claimed |
| EP-3247328-B1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | GENEVANT SCIENCES GMBH (CH) | 2026-01-07 | — | — | EP | disclosed |
| US-20250276000-A1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | GENEVANT SCIENCES GMBH (CH) | 2025-09-04 | — | — | US | disclosed |
| US-20250186599-A1 | BLOCK COPOLYMERS | GENEVANT SCIENCES GMBH (CH) | 2025-06-12 | — | — | US | disclosed |
| US-20240325552-A1 | BLOCK COPOLYMERS | GENEVANT SCIENCES GMBH (CH) | 2024-10-03 | — | — | US | disclosed |
| US-11938191-B2 | Block copolymers | GENEVANT SCIENCES GMBH (CH) | 2024-03-26 | — | — | US | disclosed |
| CN-116964228-A | Composition and method for waterproofing leather | 斯塔尔国际有限公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-116903512-A | De-glu-insulin intermediate and preparation method of de-glu-insulin | 浙江湃肽生物股份有限公司深圳分公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-109666121-B | Hybrid dynamic cross-linked polymer and application thereof | 厦门逍扬运动科技有限公司 | 2023-09-22 | — | — | CN | disclosed |
| US-20230135432-A1 | POLYMERIC NANOPARTICLES AND DERIVATIVES THEREOF FOR NUCLEIC ACID BINDING AND DELIVERY | UNIV MASSACHUSETTS (US) | 2023-05-04 | — | — | US | disclosed |
| WO-2012039855-A1 | PH-SENSITIVE COMPOSITIONS FOR DELIVERY OF BETA LAPACHONE AND METHODS OF USE | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-03-29 | — | — | WO | disclosed |
| US-20110286957-A1 | MULTIBLOCK COPOLYMERS | PHASERX, INC. (US) | 2011-11-24 | — | — | US | disclosed |
| EP-2364330-A2 | MULTIBLOCK COPOLYMERS | University Of Washington (US) | 2011-09-14 | — | — | EP | disclosed |
| WO-2011062965-A2 | TARGETING MONOMERS AND POLYMERS HAVING TARGETING BLOCKS | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2011-05-26 | — | — | WO | disclosed |
| WO-2011060281-A1 | HYDROPHOBIC BLOCK CONJUGATED THERAPEUTIC AGENTS | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2011-05-19 | — | — | WO | disclosed |
| US-20100234565-A1 | MOLECULARLY IMPRINTED POLYMERS FOR THE RECOGNITION OF GLUTATHIONE GSH, METHODS FOR PREPARING SAME AND USES THEREOF | POLYINTELL (FR) | 2010-09-16 | — | — | US | disclosed |
| US-20100234565-A1 | MOLECULARLY IMPRINTED POLYMERS FOR THE RECOGNITION OF GLUTATHIONE GSH, METHODS FOR PREPARING SAME AND USES THEREOF | POLYINTELL (FR) | 2010-09-16 | — | — | US | disclosed |
| WO-2010054266-A2 | MULTIBLOCK COPOLYMERS | UNIVERSITY OF WASHINGTON (US) | 2010-05-14 | — | — | WO | disclosed |
| WO-2009056716-A1 | MOLECULARLY IMPRINTED POLYMERS FOR THE RECOGNITION OF GLUTATHIONE GSH, METHODS FOR PREPARING SAME AND USES THEREOF | POLYINTELL (FR) | 2009-05-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250186599-A1 | BLOCK COPOLYMERS | CHMP4B, CD47, EEA1 | LMNA 1251/4885EHMT2 4383/4885EHMT1 4540/4885 |
| US-20250276000-A1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | CD63, LIPA, NPC1L1 | LMNA 146/4885EHMT2 4251/4885EHMT1 4421/4885 |
| US-11938191-B2 | Block copolymers | CHMP4B, CD47, EEA1 | LMNA 1251/4885EHMT2 4383/4885EHMT1 4540/4885 |
| US-20240325552-A1 | BLOCK COPOLYMERS | CHMP4B, CD47, EEA1 | LMNA 1251/4885EHMT2 4383/4885EHMT1 4540/4885 |
| US-20110286957-A1 | MULTIBLOCK COPOLYMERS | ABCB4, CD47, MCL1 | LMNA 1530/4885EHMT2 3236/4885EHMT1 3595/4885 |
| US-20160206750-A1 | BLOCK COPOLYMERS | CHMP4B, CD47, EEA1 | LMNA 1251/4885EHMT2 4383/4885EHMT1 4540/4885 |
| US-20230135432-A1 | POLYMERIC NANOPARTICLES AND DERIVATIVES THEREOF FOR NUCLEIC ACID BINDING AND DELIVERY | SNRPE, HNRNPAB, MTREX | LMNA 125/4885EHMT2 3258/4885EHMT1 3540/4885 |
| US-20100234565-A1 | MOLECULARLY IMPRINTED POLYMERS FOR THE RECOGNITION OF GLUTATHIONE GSH, METHODS FOR PREPARING SAME AND USES THEREOF | GSTM2, GSTP1, GSTM1 | LMNA 4844/4885EHMT2 135/4885EHMT1 149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.